Marcus Whitney & Vic Gatto

Health:Further

Health EN ↓ 214 episodes

Every week, healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney review and unpack the happenings in US Healthcare, finance, technology and policy. With a firm belief that our healthcare system is doomed without entrepreneurship, they work through the mud to find the jewels, highlight headwinds and tailwinds, and bring on the smartest guests to fill in the gaps.

Be sure to visit the podcast's website and support the creator: jumpstarthealth.co

Author

Marcus Whitney & Vic Gatto

Category

Health

Podcast website

jumpstarthealth.co

Latest episode

Nov 6, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android almost 10M downloads · 4.7+ rating iOS soon

Episodes

39 - Wall Street Record Highs | Humana to Reprice MA Plans | AI at Davos and Deep Fake Biden Calls | Steward Health in Trouble (again) 26.01.2024

Episode 39 covers the recent surge in Wall Street's performance and its potential consequences, Humana's decision to reprice its Medicare Advantage plans, the use of AI at Davos and the emergence of deep fake Biden calls, Steward Health's recurring challenges, and the significance of healthcare consumerism tools in empowering individuals to make informed healthcare choices. Please check out our Ep...

38 - Healthcare Policy & Regulation with Emily Evans 23.01.2024

In this deep dive into Healthcare Policy & Regulation with Emily Evans, we discuss the Supreme Court's upcoming review of the Chevron deference and its likely effects on healthcare regulatory agencies including HHS, CMS, FDA and FTC. We also discuss the expected positive impact on healthcare M&A markets. While potential policy changes create short-term uncertainty, they also present opport...

37 - Mixed Economic Signals | Alarming Cancer Rates | Apple & Epic Flex Market Power | General Catalyst’s Big Swing | Humana’s Medical Cost 19.01.2024

Alarming rise in cancer rates and its implications for public health? Ongoing power struggle between tech giants Apple and Epic Games, as they flex their market influence? General Catalyst's ambitious moves in the business landscape and the potential ripple effects? Join us as we navigate through these pressing issues and so much more! Please check out our Episode Resources below: ------🔎RESOURCE...

36 - Jefferson Strengthens Payor Unit | Carta Oversteps Authority | Mayo Clinic’s AI Initiative | Pushback Against Federal Agencies 12.01.2024

In this episode, we discuss Jefferson's efforts to bolster its payor unit, exploring the potential impacts on healthcare services and patient costs. We also examine the controversy surrounding Carta's alleged overstepping of its authority, shedding light on the implications for the company and its stakeholders. We take a closer look at Mayo Clinic's ambitious AI initiative, discussing its potentia...

35 - GenAI's Legal Challenge | Investors Questioning VC Valuations | Lilly Going Direct to Consumers | Elevance Adds Large Infusion Service 06.01.2024

Welcome to the first episode of 2024! In this episode, we are addressing the following topics and more: GenAI's Legal Challenge Investors Questioning VC Valuations Lilly Going Direct to Consumers Elevance Adds Large Infusion Service Secret to Longevity & Happiness Please check out our Episode Resources below: ------🔎RESOURCES🔎 Things are about to get a lot worse for Generative AI (Substack:...

34 - Predictions for Healthcare in 2024 | Apple Watch’s Pulse Oximeter IP Challenges | Gratitude for Listeners & Growth Plans for Next Year 29.12.2023

In this special year-end episode, we discuss upcoming healthcare trends for 2024, including predictions and potential challenges for Apple Watch's pulse oximeter IP. As our last episode of 2023, we also express our immense gratitude to our listeners and share H:F's growth plans for the coming year! Please check out our Episode Resources below: ------🔎RESOURCES🔎 Apple to Halt Watch Sales as It Pr...

33 - Medicare Advantage Deep-Dive with Emily Evans from Hedgeye 22.12.2023

In this episode, join us for a comprehensive exploration of Medicare Advantage as we delve into its intricacies with special guest Emily Evans from Hedgeye. Gain valuable insights into the complexities of this vital healthcare program and discover the latest developments shaping its future. ------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/ ------📱FOLLOW HEALTH:FUR...

32 - US Fed Looks for an Economic Soft-Landing | VC Bullwhip Effect | Kroger Health’s Strategic Shift | Google & HCA’s AI Collaboration 16.12.2023

In Episode 32 of the Health:Further Podcast, we cover the following key topics: US Federal Reserve's pursuit of an economic soft-landing and its potential impact on healthcare and the broader market. Unraveling the VC bullwhip effect and its influence on healthcare investments and entrepreneurial opportunities. Analyzing Kroger Health's strategic shift and its implications for the health and welln...

31 - CVS Pivots to Transparent Pricing | Pharma Leveraging Data Science | Google Unveils New AI tool | Small VC Funds Perform Best 09.12.2023

In this episode, we discuss CVS's move toward transparent pricing, the pharmaceutical industry's embrace of data science, Google's latest AI tool, the success of small VC funds, and an outlook on healthcare for 2024. Please check out our Episode Resources below: ------🔎RESOURCES🔎 Biden Announces Actions to Lower Health Care and Drug Costs (White House) // https://bit.ly/3NktJ5h CVS Says It Will...

30 - Cigna & Humana Merger while UHG Shows Reach & Scale | CMS Decreases Physician Payments, but adds New Programs | Global & Economic Power 02.12.2023

In this episode, we discuss the following topics and the latest developments shaping the healthcare landscape: Cigna and Humana Merger: We explore the potential implications of this significant merger and its impact on the industry's competitive dynamics. UHG's Reach and Scale: We analyze UnitedHealth Group's expanding influence and its implications for the broader healthcare market. CMS Physician...

29 - Exclusive Interview w/ AI Healthcare Pioneer - Dr. Tarun Kapoor of Virtua Health | BTS Analysis of the OpenAI Value Destruction 23.11.2023

In this Episode, Vic and Marcus have a conversation with Dr. Tarun Kapoor, who serves as the Senior Vice President and Chief Digital Transformation Officer at Virtua Health. Dr. Kapoor is responsible for overseeing Virtua’s Digital Transformation Office and orchestrates Virtua’s enterprise-wide master plan in support of an intuitive care journey for all consumers. Additionally, the episode delves...

28 - Inflation Slowing | Biden on Women’s Health Research | Amazon Advances One Medical | Healthcare AI 17.11.2023

This episode covers a range of significant developments in the healthcare sector. Marcus and Vic discuss the impact of slowing inflation on healthcare costs, President Biden's research focus on women's health, the collaboration between Amazon and One Medical, the emergence of transparency in pharmacy benefit managers, and the latest advancements in healthcare AI. Join us as we explore these topics...

27 - First Health System Adopts AI for Patient Care | Digital Clones Arrive | Explosion AI Stories | Healthcare News Roundup 10.11.2023

In Episode 27 of the Health:Further podcast, Vic and Marcus discuss the first health system to adopt AI for patient care, the arrival of digital clones, and exciting AI stories. They also cover a healthcare news roundup, including Virtua Health's introduction of AI therapists and the ability to create AI clones with Delphi Jobs, Bezos, and Oppenheimer. Tune in for a concise and informative episode...

26 - Debate on the Role Govt. Should Play in AI Regulation | Venture Markets | Pharmacists Walk-out 04.11.2023

In this episode, Marcus and Vic engage in a healthy debate surrounding the crucial question of the government's role in regulating AI as they dive into the complexities of balancing innovation and ethical considerations, exploring the potential risks and benefits associated with various regulatory approaches. They also discuss the latest developments in federal policies impacting the tech industry...

25 - Macro Forces Drive Insolvency & Defragmentation | GDP Growth | Seed-Stage Reset | Meta Lawsuit 27.10.2023

In the 25 episodes of Health:Further, three major themes have emerged. Firstly, macroeconomic forces are exerting significant pressure on the healthcare industry, with inflation negatively affecting health systems and the actions of the Federal Reserve and interest rates impacting capital markets. Public equity and bond markets play a crucial role in providing capital to all sectors of the healthc...

24 - Opioid Treatment on the Streets of Philadelphia | 3 Key Announcements from HLTH | Kaiser’s Resolution with Labor 20.10.2023

Welcome to Episode 24 of Health:Further, where we dive into pressing healthcare issues and industry news. In this episode, we explore the challenges and innovations surrounding opioid treatment on the streets of Philadelphia. We also discuss three key announcements from the HLTH conference and Kaiser Permanente's resolution with labor. Join us as we examine many other topics surrounding the latest...

23 - A Poignant Insider’s View of Healthcare’s Importance to Patients and Their Families 07.10.2023

In this episode, Marcus and Vic discussed several significant events currently taking place. One notable development is the closure of many Carta startups, indicating a challenging period for the industry. Additionally, Representative Matt Gaetz's push to remove Speaker Kevin McCarthy from his position created anticipation for an intense confrontation between McCarthy and his conservative opponent...

22 - Chronicling Healthcare’s End Times: Rite Aid, HealthComp, Pharma, FTC & Government Shutdown 29.09.2023

In Episode 22 of Health:Further, we'll be covering a range of topics, including: Rite Aid plans to shutter stores in bankruptcy, and private equity-owned healthcare companies are merging in a $3 billion deal. The broken business model in the pharmaceutical industry hinders the development of new antibiotics, and a shortage of a life-saving cancer therapy persists. Elevance and Blue Cross Louisiana...

21 - Let’s Get the Easy Decisions Right: Reauthorize AIDS Treatment | Stay out of Small Healthcare Acquisitions | Fund the Government 23.09.2023

In Episode 21 of Health:Further, we'll be covering a range of topics, including: "Republicans and the Lifesaving Government Initiative": Twenty years ago, the Republican Party initiated a groundbreaking government program that has had a profound impact on global AIDS prevention, saving a remarkable 25 million lives to date—equivalent to the entire population of Australia. However, there are concer...

20 - Making Healthcare Better Means Fixing Our Trust Problem 15.09.2023

In episode 20 of Health:Further, we'll be covering some interesting topics, including: Walgreens teaming up with Pearl Health, a primary care enablement tech company, to expand its efforts in value-based care. The steep rise in health insurance costs, with experts predicting the biggest increase in over a decade, which could have a major impact on businesses and their employees in 2024. An advisor...

19 - Aspen Institute Health Innovators Fellowship Conversations | Podcast Collab with Portal Innovations 11.09.2023

Episode 19 was recorded during the Aspen Institute Health Innovators Fellowship Reunion in Chicago, IL. This special episode is presented in partnership with Portal Innovations and their podcast, Lab Rats to Unicorns , hosted by Portal Innovations Founder and CEO, John Flavin . John is the Founder and CEO of Portal Innovations, a premier venture development engine that builds and invests in life s...

18 - Rethinking “Cancer” & Correcting Embedded Racial Bias | Reinventing Start-up Strategies | HCA & Google Collaborate on AI Innovation 01.09.2023

In episode 18 of Health:Further, we will dive into various topics. Firstly, we will examine the 4.20 percent increase in the Redbook Index in the United States for the week ending August 26, 2023, compared to the same week in the previous year. Additionally, we will discuss Questa Capital's successful closure of a $397 million Healthcare Venture Fund. We will also be exploring HCA Healthcare's rec...

17 - Death of a Healthcare Unicorn | New Federal Tax and SEC Rules | Gender Clinic Struggles to Provide Care 26.08.2023

In episode 17, we will be discussing various topics including the recent developments in Truepill, a startup that handles the shipment of prescription drugs for online pharmacies like Hims, Mark Cuban's Cost Plus Drugs, and GoodRx. According to a recent filing from Prime Unicorn Index, Truepill has authorized a significant reduction of over 90% in the price of some of its shares compared to their...

16 - Healthcare Recognized as #1 Inc. 5000 | Consumer Financial Health in 7 Charts | Ideas to Make Needed Improvements in Medicaid 18.08.2023

The fastest growing company in the US is solving healthcare's biggest challenge. Many health systems are pulling back from venture capital. The consequences of Medicaid's unwinding of continuous coverage are overwhelming. Prior authorization reduction is equal to nearly 20 percent of volume overall. We're taking an in-depth look at these topics and more in Episode 16. ------🔎RESOURCES🔎 AMERICA'S...

15 - AI Chatbots as Friends | US CPI at 3.2%, but Deflation in China | Hospital Prices set by CMS for 2024 | Wegovy for Heart Disease 11.08.2023

The Bureau of Labor Statistics reported that the CPI rose 3.2% in July from year-ago levels, a slight increase from June’s 3.0%, but well below last summer’s peak of 9.1%. Americans’ collective credit-card bill rose to $1.03 trillion from $986 billion in the first quarter, according to the household debt report released Tuesday by the Federal Reserve Bank of New York. While AI’s abilities continue...

Listen to the Health:Further podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.